Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript

Envista Holdings Corporation ( NVST ) Analyst/Investor Day September 17, 2026 9:00 AM EDT Company Participants Jim Gustafson - Vice President of Investor Relations Paul Keel - President, CEO & Chairman Stefan Nilsson - President of Nobel Biocare Veronica Acurio - Senior VP & President of Orthodontics Filippo Impieri - President of Consumables Robert Befidi - Senior VP & President of Diagnostics Eric Hammes - Senior VP & CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jason Bednar - Piper Sandler & Co., Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Kevin Caliendo - UBS Investment Bank, Research Division Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Allen Lutz - BofA Securities, Research Division Presentation Jim Gustafson Vice President of Investor Relations Good morning, everyone. I'm Jim Gustafson, Vice President of Investor Relations for Envista, and it's my pleasure to welcome you to our 2026 Investor Day. We want to thank you for your interest in our company. And a special thanks to those of you who've made the journey to join us in-person here at our Nobel Biocare facility in Mahwah, New Jersey. I'd like to remind you that during the presentation, that we are sharing today, it will also be available for download at the Events & Presentations section of our IR website at investors.envistaco.com. Additionally, this is being webcast live on the same Events and Presentations section of our IR website and will be available for replay later today after the event has concluded. So in our presentation today, we will make forward-looking statements within the meaning of the federal securities laws. These statements are subject to